BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32689909)

  • 1. Molecular Determinants of Thyroid Nodules with Indeterminate Cytology and
    Hernandez-Prera JC; Valderrabano P; Creed JH; de la Iglesia JV; Slebos RJC; Centeno BA; Tarasova V; Hallanger-Johnson J; Veloski C; Otto KJ; Wenig BM; Yoder SJ; Lam CA; Park DS; Anderson AR; Raghunand N; Berglund A; Caudell J; Gerke TA; Chung CH
    Thyroid; 2021 Jan; 31(1):36-49. PubMed ID: 32689909
    [No Abstract]   [Full Text] [Related]  

  • 2. Utility of a multigene testing for preoperative evaluation of indeterminate thyroid nodules: A prospective blinded single center study in China.
    Song Y; Xu G; Ma T; Zhu Y; Yu H; Yu W; Wei W; Wang T; Zhang B
    Cancer Med; 2020 Nov; 9(22):8397-8405. PubMed ID: 32976686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAS mutations in indeterminate thyroid nodules are predictive of the follicular variant of papillary thyroid carcinoma.
    An JH; Song KH; Kim SK; Park KS; Yoo YB; Yang JH; Hwang TS; Kim DL
    Clin Endocrinol (Oxf); 2015 May; 82(5):760-6. PubMed ID: 25109485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study.
    Steward DL; Carty SE; Sippel RS; Yang SP; Sosa JA; Sipos JA; Figge JJ; Mandel S; Haugen BR; Burman KD; Baloch ZW; Lloyd RV; Seethala RR; Gooding WE; Chiosea SI; Gomes-Lima C; Ferris RL; Folek JM; Khawaja RA; Kundra P; Loh KS; Marshall CB; Mayson S; McCoy KL; Nga ME; Ngiam KY; Nikiforova MN; Poehls JL; Ringel MD; Yang H; Yip L; Nikiforov YE
    JAMA Oncol; 2019 Feb; 5(2):204-212. PubMed ID: 30419129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules.
    Beaudenon-Huibregtse S; Alexander EK; Guttler RB; Hershman JM; Babu V; Blevins TC; Moore P; Andruss B; Labourier E
    Thyroid; 2014 Oct; 24(10):1479-87. PubMed ID: 24811481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytological features and nuclear scores: Diagnostic tools in preoperative fine needle aspiration of indeterminate thyroid nodules with RAS or BRAF K601E mutations?
    Ravella L; Lopez J; Descotes F; Giai J; Lapras V; Denier ML; Borson-Chazot F; Lifante JC; Decaussin-Petrucci M
    Cytopathology; 2021 Jan; 32(1):37-44. PubMed ID: 32803788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective analysis of cancer-specific gene expression panel for thyroid fine needle aspiration specimens.
    Wang Y; McKelvey BA; Liu Z; Rooper L; Cope LM; Zeiger MA; Umbricht CB
    J Cancer Res Clin Oncol; 2021 Oct; 147(10):2983-2991. PubMed ID: 34165589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAS-positive thyroid nodules.
    Angell TE
    Curr Opin Endocrinol Diabetes Obes; 2017 Oct; 24(5):372-376. PubMed ID: 28639967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilities of
    Guan H; Toraldo G; Cerda S; Godley FA; Rao SR; McAneny D; Doherty G; Braverman L; Lee SL
    Thyroid; 2020 Apr; 30(4):536-547. PubMed ID: 31996097
    [No Abstract]   [Full Text] [Related]  

  • 10. Preoperative Role of RAS or BRAF K601E in the Guidance of Surgery for Indeterminate Thyroid Nodules.
    Ravella L; Lopez J; Descotes F; Giai J; Lapras V; Denier ML; Borson-Chazot F; Lifante JC; Decaussin-Petrucci M
    World J Surg; 2020 Jul; 44(7):2264-2271. PubMed ID: 32227276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mutational analysis in the diagnostic work-up of thyroid nodules: the real impact in a center with large experience in thyroid cytopathology.
    Macerola E; Rago T; Proietti A; Basolo F; Vitti P
    J Endocrinol Invest; 2019 Feb; 42(2):157-166. PubMed ID: 29704233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomorphologic features in thyroid nodules read as "suspicious for malignancy" on cytology may predict thyroid cancers with the BRAF mutation.
    Kwon HJ; Kim EK; Kwak JY
    Pathol Res Pract; 2015 Sep; 211(9):671-6. PubMed ID: 26187369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The histologic outcomes of indeterminate thyroid nodules with rat sarcoma mutations: A case series.
    Jones M; Abendano DG; Turner M; Sullivan C; Reyes MCD
    Diagn Cytopathol; 2023 Dec; 51(12):E332-E337. PubMed ID: 37583345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular testing for indeterminate thyroid nodules: Performance of the Afirma gene expression classifier and ThyroSeq panel.
    Jug RC; Datto MB; Jiang XS
    Cancer Cytopathol; 2018 Jul; 126(7):471-480. PubMed ID: 29637728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on the performance of the Afirma gene expression classifier.
    Hang JF; Westra WH; Cooper DS; Ali SZ
    Cancer Cytopathol; 2017 Sep; 125(9):683-691. PubMed ID: 28544601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the likelihood of malignancy in thyroid nodules with RAS mutations increase in direct proportion with the allele frequency percentage?
    Hudson TJ; Pusztaszeri MP; Hier MP; Forest VI; Yang JW; Payne RJ
    J Otolaryngol Head Neck Surg; 2023 Feb; 52(1):12. PubMed ID: 36774522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAS Mutations in AUS/FLUS Cytology: Does it Have an Additional Role in BRAFV600E Mutation-Negative Nodules?
    Yoon JH; Kwon HJ; Lee HS; Kim EK; Moon HJ; Kwak JY
    Medicine (Baltimore); 2015 Jul; 94(27):e1084. PubMed ID: 26166089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplatform molecular test performance in indeterminate thyroid nodules.
    Lupo MA; Walts AE; Sistrunk JW; Giordano TJ; Sadow PM; Massoll N; Campbell R; Jackson SA; Toney N; Narick CM; Kumar G; Mireskandari A; Finkelstein SD; Bose S
    Diagn Cytopathol; 2020 Dec; 48(12):1254-1264. PubMed ID: 32767735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative detection of RAS mutation may guide extent of thyroidectomy.
    Patel SG; Carty SE; McCoy KL; Ohori NP; LeBeau SO; Seethala RR; Nikiforova MN; Nikiforov YE; Yip L
    Surgery; 2017 Jan; 161(1):168-175. PubMed ID: 27863786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of "Carcinomas" Harboring RAS Mutations.
    Paulson VA; Shivdasani P; Angell TE; Cibas ES; Krane JF; Lindeman NI; Alexander EK; Barletta JA
    Thyroid; 2017 Apr; 27(4):506-511. PubMed ID: 28114855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.